Kalbe Farma Tbk PT ADR

Price Chart

Risk-Adjusted Performance

Kalbe Farma Tbk PT ADR (PTKFY) Price Performance

Kalbe Farma Tbk PT ADR (PTKFY) trades on United States in USD. The company is classified in the Healthcare sector under the Drug Manufacturers - General industry. The stock currently trades at $12.30.

Over the past year, PTKFY has traded between a low of $12.00 and a high of $19.50. The stock has lost 10.3% over this period. It is currently 36.9% below its 52-week high.

Kalbe Farma Tbk PT ADR has a market capitalization of $2.72B and a dividend yield of 368.00%.

About Kalbe Farma Tbk PT ADR

PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business; and E-health products. It operates Mitrasana Clinics, a health care service. In addition, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services. The company was incorporated in 1966 and is headquartered in Jakarta, Indonesia.